Taglich Brothers Expects Weaker Earnings for Cosmos Health

Cosmos Health Inc. (NASDAQ:COSM) – Equities research analysts at Taglich Brothers reduced their Q3 2025 earnings estimates for shares of Cosmos Health in a report released on Monday, November 25th. Taglich Brothers analyst H. Halpern now forecasts that the company will post earnings of ($0.01) per share for the quarter, down from their previous forecast of $0.03. The consensus estimate for Cosmos Health’s current full-year earnings is ($0.48) per share. Taglich Brothers also issued estimates for Cosmos Health’s Q4 2025 earnings at $0.04 EPS.

Cosmos Health Trading Up 3.2 %

Shares of NASDAQ:COSM opened at $0.81 on Wednesday. The company’s 50-day moving average price is $0.78 and its two-hundred day moving average price is $0.91. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.44 and a quick ratio of 1.24. Cosmos Health has a one year low of $0.47 and a one year high of $1.65. The stock has a market capitalization of $18.91 million, a PE ratio of -0.32 and a beta of 5.72.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.